Lundbeck partner Forest reports increasing Q4 sales of depression ... CNNMoney.com - ... Inc. (NYSE:FRX) reported a nine percent year-on-year increase in sales of Lundbeck's depression treatment Lexapro during the fourth quarter. ... Danish shares close higher; Novozymes down on broker downgrade UPDATE |
Tuesday, April 15, 2008
Lundbeck partner Forest reports increasing Q4 sales of depression ... - CNNMoney.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment